Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Munich - Delayed Quote • EUR DocCheck AG (AJ91.MU) Follow Add holdings 11.20 +0.30 +(2.75%) As of 8:00:05 AM GMT+2. Market Open. Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for AJ91.MU 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: AJ91.MU View More All News Press Releases SEC Filings DocCheck Full Year 2024 Earnings: EPS: €1.04 (vs €0.45 in FY 2023) DocCheck AG's (ETR:AJ91) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong? DocCheck (ETR:AJ91) Will Want To Turn Around Its Return Trends DocCheck (ETR:AJ91) earnings and shareholder returns have been trending downwards for the last three years, but the stock hikes 12% this past week DocCheck AG's (ETR:AJ91) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced? There May Be Reason For Hope In DocCheck's (ETR:AJ91) Disappointing Earnings DocCheck (ETR:AJ91) Is Reinvesting At Lower Rates Of Return We Wouldn't Be Too Quick To Buy DocCheck AG (ETR:AJ91) Before It Goes Ex-Dividend Should Weakness in DocCheck AG's (ETR:AJ91) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?